BioSpace News Archive

TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, announced today that members of management will be presenting at the virtual Canaccord 40th Annual Growth Conference.

Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases and other public health threats for civilian, government and military use, today announced the Company will host a conference call and live audio webcast on Monday, August 10, 2020 at 8:30 a.m.

Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) today announced it will release financial results for the second quarter of 2020 after market close on Tuesday, August 11, 2020.

Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today reported financial results for its second quarter ended June 30, 2020.

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, announced that the company will participate in two upcoming investor conferences.

Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced results for its second quarter ended June 30, 2020.

Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock, in an underwritten public offering

NetNoggin®, a premier market research agency that specializes in the pharmaceutical industry, has announced the release of its newest research report, NetNog: #genesis® Cystic Fibrosis V2.0 with updates due to TRIKAFTA.

Research led by the Children’s Oncology Group (COG) and NRG Oncology, and supported by the St. Baldrick’s Foundation, discovered that adding pazopanib, a type of chemotherapy, to preoperative chemoradiotherapy improves response to treatment for soft tissue sarcoma patients, compared with chemoradiotherapy alone

Nashville NeuroCare Therapy, the flagship neuroCare Centers of America clinic in Tennessee, today announced it is celebrating its 10-year anniversary of providing Transcranial Magnetic Stimulation (TMS) Therapy for depression, as the company continues to focus on leveraging innovative technologies and its personalized care approach of providing medication-free treatment options.